Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Clinical trial NCT03450122 · COMPLETED

Trial details

NCT number: NCT03450122
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HLA-A*0201 Positive Cells Present NY-ESO-1 Positive Tumor Cells Present Recurrent Myxoid Liposarcoma Recurrent Synovial Sarcoma

Start date: 2018-09-13
Primary completion: 2022-12-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.